Sucampo, Takeda deal

Takeda received a license to market Sucampo's Lubiprostone in the U.S. and Canada.

Read the full 133 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE